← Leaderboards
Joseph Sparano
Montefiore Medical Center /Inc
$1,937,101
Attributed
$1,937,101
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.8K · FY2006–11$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,937,101 · 2
By mechanism
N01$1,937,101 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tumor Tissue”
- David Heimbrook · Leidos Biomedical Research, Inc.$329,212,748
- Timothy J Eberlein · Washington University$86,792,803
- Larry Arthur$85,804,691
- Richard L Schilsky · University Of Chicago$80,448,107
- Monica M Bertagnolli · Strang Cancer Prevention Center$75,743,395
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$72,731,981
Research focus
Tumor TissueBaseBloodScheduleTherapeutic DevelopmentTumorAntitumor AgentCancer Therapy Evaluation ProgramClinically RelevantClinical TrialsCombined Modality TherapyConduct Clinical TrialsContractorContractsData ReportingDevelopment PlansDoseDrug DevelopmentDrug KineticsElderlyEthnic GroupEvaluation ResearchImage AnalysisMalignant Neoplasms
Grant awards (5)
Early Therapeutics Development with Phase II Emphasis$472,963
N01 · FY2011 · CA · contact PI
Early Therapeutics Development with Phase II Emphasis$522,381
N01 · FY2010 · CA · contact PI
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8376$799,986
N01 · FY2009 · CA · contact PI
Early Therapeutics Development with Phase II Emphasis$141,771
N01 · FY2009 · CA · contact PI
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS-261622004$0
N01 · FY2006 · CM · contact PI